Asia Pacific Pharmaceutical Packaging Market

The report "Asia Pacific Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery (Oral, Injectables, Topical), Packaging Type, Raw Material, And Country - Forecast to 2030" The Asia Pacific pharmaceutical packaging market is projected to grow from USD 52.15 billion in 2025 to USD 119.48 billion by 2030, at a CAGR of 18% during the forecast period.

Browse 200 market data Tables and 50 Figures spread through 250 Pages and in-depth TOC on "Asia Pacific Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery (Oral, Injectables, Topical), Packaging Type, Raw Material, And Country - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-pharmaceutical-packaging-market-179516169.html

The Asia Pacific pharmaceutical packaging market, encompassing the major countries of China, India, Japan, South Korea, and Australia, is undergoing a rapid development phase and is supported by the growth of pharmaceutical, biotechnology, and vaccine manufacturing sectors. This development is not only being caused by the increasing demand for medicines but also by the concurrent introduction of advanced packaging formats such as high-barrier blister packs, prefilled syringes, vials, cartridges, and temperature-controlled solutions for the biologics and specialty drugs market. The countries which have the greatest influence on the outbound and local drug markets are China and India, while Japan and South Korea are associated with the use of top quality, tech-based packaging for injections and special therapies. Demand is also being created in Australia by the strong regulatory standards and the active clinical trial environment. The major contributor to the long-term growth of the region is the never-ending investment in packaging innovations, serialization, sustainability practices, and compliance with the global regulations.

Injectables are the fastest-growing drug delivery segment of the Asia Pacific pharmaceutical packaging market, in terms of value, during the forecast period.

Injectables are leading the charge in terms of value as they are the fastest-growing drug delivery segment in the Asia Pacific pharmaceutical packaging market, mainly due to the quick spread of biologics, vaccines, biosimilars, and specialty injectable drugs all over the region. China, India, South Korea, and Japan are quite extensively boosting their production for vaccines, monoclonal antibodies, insulin, and oncology injectables, among others, which all require high-value packaging like vials, ampoules, prefilled syringes, and cartridges. These products impose a lot on sterile, high-precision, and regulatory-compliant primary packages, which are more costly than the packaging for oral drugs. Moreover, the increasing incidence of chronic diseases, better hospital-based treatments, and extensive immunization programs are driving the use of injectable drugs. The growing trend toward patient-friendly prefilled delivery systems and temperature-controlled packaging further contributes to the overall packaging value, thus classifying injectables as the fastest-growing segment during the forecast period.

Prefilled syringes is the fastest-growing segment by type for Asia Pacific pharmaceutical packaging market, in terms of value, during the forecast period.

The Asia Pacific pharmaceutical packaging market is experiencing rapid growth in the prefilled syringes segment, which has been the fastest-growing type in terms of value mainly due to the rapid rise in injectable therapies, biologics, vaccines, and chronic disease treatments. The healthcare systems in China, India, Japan, and South Korea are embracing the prefilled systems as they effectively reduce dosing errors, increase patient safety, and allow quicker drug administration. In addition, prefilled syringes have the ability to elevate the pharmaceutical products' quality by providing the aforementioned benefits such as drug stability, minimization of contamination risk, and improved convenience for both hospital and home-care settings.

Primary is the faster-growing packaging type in the Asia Pacific pharmaceutical packaging market during the forecast period, in terms of value.

In Asia Pacific, primary packaging has become the leading type of packaging in the market, since it provides the drug with its first step of protection and at the same time is the most critical contributing factor to safety, stability, and regulatory compliance. The demand for primary packaging that possesses high value is strong and mainly comes from the rapid growth of injectables, biologics, vaccines, and specialty drugs in countries like China, India, Japan, and South Korea. Vials, ampoules, prefilled syringes, cartridges, and high-barrier blister packs are some of the primary packaging categories that are in strong demand. These products necessitate the use of sterile, precision-engineered and contamination-free packaging which is priced significantly higher than secondary packaging. Moreover, the stricter regulations on drug safety, serialization, and tamper-evidence are escalating the demand for advanced primary packaging solutions. The increasing pharmaceutical exports from Asia Pacific are another factor that drives manufacturers to adopt premium, compliant primary packaging that is considered to be the fastest growing segment during the forecast period in terms of value.

China holds the largest share in the Asia Pacific pharmaceutical packaging market during the forecast period, in terms of value.

The pharmaceutical packaging market in Asia Pacific is dominated by China in terms of value as it is the biggest pharmaceutical manufacturing base, possesses a strong position in the production of active pharmaceutical ingredients, and has a rapidly growing production of finished dosage forms, vaccines, and biologics among others. Besides, the country is still a major global supplier of medicines, which maintains a demand for packing of vials, blister packs, bottles, and prefilled systems at the same time high in volume and quality. Furthermore, China has a very good packaging manufacturing ecosystem backed by the scale of production of plastics, glass, aluminum, and advanced packaging components which allow the cost to be kept low and the supply to be reliable. On top of that, the tightening of regulations, serialization requirements, and the increase in the export of drugs to regulated markets are the factors that are forcing pharmaceutical manufacturers to go for high-value, compliant packaging solutions which in turn is making China occupy an even larger share of the pharmaceutical packaging market in Asia Pacific.

Key players

The key players in the Asia Pacific pharmaceutical packaging market include Amcor plc (Switzerland), Gerresheimer AG (Germany), SCHOTT AG (Germany), Becton Dickinson & Co (US), WestRock Company (Ireland), AptarGroup, Inc (US), West Pharmaceutical Services, Inc (US), Parekhplast India Ltd. (India), Nipro Corporation (Japan), and SGD Pharma (France).

Don’t miss out on business opportunities in Asia Pacific Pharmaceutical Packaging Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com